Epo-Induced Hemoglobinhation of SKT6 Cells is Mediated by Minimal Cytoplasmic Domains of the Epo or Prolactin Receptors without Modulation of GATA-1 or EKLF

Growth Factors

Volumn 14, Issue 42038, 1997, Pages 161-176

  Reese, Tamara T ^a   Gregory, Richard C ^a   Shafuow, Elizabeth R ^a   Pacifici, Robert E ^b   Crouse, Jill A ^b   Todokorog, Kazuo ^c   Wojchowski, Don M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b AMGEN INC   (United States)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Erythroid differentiation; erythropoiesis; erythropoietin; SKT6 cells

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLOBIN; HEMOGLOBIN; PROLACTIN RECEPTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; ERYTHROID CELL; GENE EXPRESSION; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STEM CELL;

AMINO ACID SEQUENCE; ANIMALS; DNA-BINDING PROTEINS; ERYTHROID PROGENITOR CELLS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; ERYTHROPOIETIN; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMOGLOBINS; JANUS KINASE 2; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; MICE, INBRED STRAINS; MILK PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, PROLACTIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030849103     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977199709021518     Document Type: Article

References (77)

1. Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA 1990; 87: 6934 – 6938
2. Ben-David Y., Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 1991; 66: 831 – 834
3. Bockamp E.-O., McLaughlin F., Murrell A. M., Gottgens B., Robb L., Begley C. G., Green A. R. Lineage-restricted regulation of the murine SCL/TAL-1 promoter. Blood 1995; 86: 1502 – 1514
4. Busfield S. J., Klinken S. P. Erythropoietin-induced stimulation of differentiation and proliferation in J2E cells is not mimicked by chemical induction. Blood 1992; 80: 412 – 419
5. Carroll M., Mathey-Prevot B., D'Andrea A. D. Differentiation domains of the erythropoietin receptor. Proc. Soc. Exp. Biol. Med 1994; 206: 289 – 294
6. Carroll M., Zhu Y., D'Andrea A. D. Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle. Proc. Natl Acad. Sci. USA 1995; 92: 2869 – 2873
7. Chardin P., Cussac D., Maignan S., Ducruix A. The Grb2 adapter. FEBS Lett 1995; 369: 47 – 51
8. Chiba T., Nagata Y., Kishi A., Sakamaki K., Miyajima A., Yamamoto M., Engel J. D., Todokoro K. Induction of erythroid-specific gene expression in lymphoid cells. Proc. Natl Acad. Sci. USA 1993; 90: 11593 – 11597
9. Crossley M., Orkin S. H. Phosphorylation of the erythroid transcription factor GATA-1. J. Biol. Chem 1994; 269: 16589 – 16596
10. D'Andrea A. D., Lodish H. F., Wong G. G. Expression cloning of the murine crythropoietin receptor. Cell 1989; 57: 277 – 285
11. D'Andrea A. D., Moreau J. F., Showers M. O. Molecular mimicry of erythropoietin by the spleen focus-forming virus gp55 glycoprotein: the first stage of Friend virus-induced erythroleukemia. Biochim. Biophys. Acta 1992; 1114: 31 – 41
12. Damen J. E., Wakao H., Miyajima A., Krosl J., Humphries R. K., Cutler R. L., Krystal G. vrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J 1995; 14: 5557 – 5568
13. Damen J., Mui A. L., Hughes P., Humphries K., Krystal G. Erythropoietin-induced tyrosine phosphorylations in a high erythropoietin receptor-expressing lymphoid cell line. Blood 1992; 80: 1923 – 1932
14. de Jong R., Haataja L., Voncken J. W., Heisterkamp N., Groffen J. Tyrosine phosphorylation of murine Crkl. Oncogene 1995; 11: 1469 – 1474
15. Douay L., Giarratana M. C., Drouet X., Bardinet D., Gorin N. C. The role of recombinant haematopoietic growth factors in human long-term bone marrow culture in serum-free medium. Br. J. Haematol 1991; 79: 27 – 32
16. Finbloom D. S., Petricoin E. F., III, Hackett R. H., David M., Feldman G. M., Igarashi K.-I., Fibach E., Wever M. J., Thomer M. O., Silva C. M., Lamer A. C. Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation. Mol. Cell. Biol 1994; 14: 2113 –?
17. Fry M. J., Waterfield M. D. Structure and function of phosphotidylinositol 3–kinase: a potential second messenger system involved in growth control. Phil. Trans. Royal S°c. London-Series B: Biol. Sci 1993; 340: 337 – 344
18. Fukumoto H., Matsui Y., Obinata M. Mechanism of erythropoietin action on the erythroid progenitor cells induced from murine erythroleukemia cells (TSA8). Development 1989; 105: 109 – 114
19. Gohert S., Chretien S., Gouilleux F., Muller O., Pallard C., Dusanter-Fourt I., Broner B., Lacombe C., Gisselbrecht S., Mayeux P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J 1996; 15: 2434 – 2441
20. Gobert S., Porteu F., Pallu S., Muller O., Sabbah M., Dusanter-Fourt I., Courtois G., Lacombe C., Gisselbrecht S., Mayeux P. Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction. Blood 1995; 8: 598 – 606
21. Hankins W. D., Chin K., Dons R., Szabo J. Isolation of erythropoictin-dependent cell lines suggests viability role for developmental hormones. Blood 1987; 70: 173a
22. He T. C., Jiang N., Zhuang H., Wojchowski D. M. Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2–associated pathway. J. Biol. Chem 1995; 270: 11055 – 11061
23. Ihle J. W., Quelle F. W., Miura O. Signal transduction through the receptor for erythropoietin. Sem. Immunol 1993; 5: 375 – 389
24. Jacobs K., Shoemaker C., Rudersdorf R., Neill S. D., Kaufman R. J., Mufson A., Seehra J., Jones S. S., Hewick R., Fritsch E. F., Kawakita M., Shimizu T., Miyake T. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985; 313: 806 – 810
25. Jiang N., He T. C., Miyajima A., Wojchowski D. M. The box 1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically witbin an interleukin 2 β-receptor chimera. J. Biol. Chem 1996; 271: 16472 – 16476
26. Kabat D. Molecular biology of Friend viral erythroleukemia. Curr Top. Microbiol. Immunol 1989; 148: 142
27. Kaiho S. I., Mizuno K. Sensitive assay systems for detection of hemoglobin with 2, 7–diaminofluorene: histochemistry and colorimetry for erythrodifferentiation. Anal. Biochem 1985; 149: 117 – 120
28. Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Pial Y. F., Miyazono K., Urabe A., Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol 1989; 140: 323 – 334
29. Klingmuller U., Lorenz U., Cantley L. C., Neel B. G., Lodish H. F. Specific recruitment of SH-PTPI to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell 1995; 80: 729 – 738
30. Klinken S. P., Nicola N. A. Evolution of a mutant J2E erythroid cell line which does not respond to erythropoietin. Leukemia 1990; 4: 24 – 28
31. Klinken S. P., Nicola N. A., Johnson G. R. In vitro-derived leukemic erythroid cell lines induced by a raf-and myc-containing retrovirus differentiate in response to erythropoietin. Proc. Natl. Acad. Sci. USA 1988; 85: 8506 – 8510
32. Koury M. J., Sawyer S. T., Bondurant M. C. Splenic erythroblasts in anemia-inducing Friend disease. a source of cells for studies of erythropoietin-mediated differentiation. J. Cell. Physiol 1984; 121: 526 – 532
33. Krantz S. B. Erythropoietin. Blood 1991; 77: 419 – 434
34. Krantz S. B., Sawada K. Growth of highly purified human CFU-E in serum-free medium. Prog. Clin. Biol. Res 1990; 352: 9 – 20
35. Krosl J., Damen J. E., Krystal G., Humphries R. K. Erythropoietin and interleukin-3 induce distinct events in erythmpoietin receptor-expressing BA/F3 cells. Blood 1995; 85: 50 – 56
36. Kuramochi S., Chiba T., Amanuma H., Tojo A., Todokoro K. Growth signal erythropoietin activates the same tyrosine kinases as interleukin 3, but activates only one tyrosine kinase as differentiation signal. Biochem. Biophy. Res. Commun 1991; 181: 1103 – 1104
37. Kuramochi S., Sugimoto Y., Ikawa Y., Todokoro K. Transmembrane signaling during erythropoietin-and dimethylsulfoxide-induced erythroid cell differentiation. Eur: J. Biochem 1990; 193: 163 – 168
38. Lebrun J. J., Ali S., Goffin V., Ullrich A., Kelley P. A. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc. Natl. Acad. Sci. USA 1995; 92: 4031 – 4035
39. Li J. P., D'Andrea A. D., Lodish H. F., Baltimore D. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 1990; 343: 762 – 764
40. Liboi E., Carroll M., D'Andrea A. D., Mathey-Prevot B. Erythropoietin receptor signals both proliferation and erythroid-specific differentiation. Proc. Natl. Acad. Sci. USA 1993; 90: 11351 – 11355
41. Lin F. K., Suggs S., Lin C. H., Browne J. K., Smalling R., Egrie J. C., Chen K. K., Fox G. M., Martin F., Stabinsky Z., Badrawi S. M., Lai P. H., Goldwasser E. Cloning and expression of the human erythropoietin gene. Proc. Natl. Acad. Sci. USA 1985; 82: 7580 – 7584
42. Liu L., Damen J. E., Rosten P., Humphries R. K., Kay R., Jefferson A. B., Majerus P. W., Krystal G. Identification of a Shc-associated 145 kDa protein as an Sh2 containing inositol polyphosphate 5–phosphatase: and analysis of its interaction with Shc. Blood 1995; 8 (suppl. 1) 252a
43. Maruyama K., Miyata K., Yoshimura A. Proliferation and erythroid differentiation through the cytoplasmic domain of the erythropoietin receptor. J. Biol. Chem 1994; 269: 5976 – 5980
44. Matsuguchi T., Inhorn R. C., Carlesso N., Xu G., Drucker B., Griffin J. D. Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3, and steel factor and is constitutively increased by p210BCR/ABL. EMBO J 1995; 14: 257 – 265
45. Migliaccio G., Migliaccio A. R., Kreider B. L., Rovera G., Adamson J. W. Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J. Cell Biol 1989; 109: 833 – 841
46. Miura O., Miura Y., Nakamura N., Quelle F. W., Witthuhn B. A., Ihle J. N., Aoki N. Induction of tyrosine phosphorylation of Vav and expression of Pim-I correlates with Jak2–mediated growth signaling from the erythropoietin receptor. Blood 1994; 84: 4135 – 4141
47. Miura O., Nakamura N., Ihle J. N., Acki N. Erythropoietin-dependent association of phosphotidylinositol 3–kinase with tyrosine-phosphorylated erythropoietin receptor. J. Biol. Chem 1994; 269: 614 – 620
48. Miyazaki T., Liu Z. J., Kawahara A., Minami Y., Yamada K., Tsujimoto Y., Barsoumian E. L., Perlmutter R. M., Taniguchi T. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and Ick cooperate in hematopoietic cell proliferation. Cell 1995; 81: 223 – 231
49. Muta K., Krantz S. B., Bondurant M. C., Dai C. H. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 1995; 86: 572 – 580
50. Nakamura Y, Nakauchj H. A truncated erythmpoietin receptor and cell death: a reanalysis. Science 1994; 264: 588 – 589
51. Nakamura Y., Komatsu N., Nakauchi H. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 1992; 257: 1138 – 1141
52. Nijhof W., Wierenga P. K. lsolation and characterization of the erythroid progenitor cell: CFU-E. J. Cell. Biol 1983; 96: 386 – 392
53. O'Neal K. D., Yu-Lee L. Differential signal transduction of the short. Nb2. and long prolactin receptors. J. Biol. Chem 1994; 269: 26076 – 26082
54. Ohashi T., Masuda M., Ruscetti S. K. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood 1995; 85: 1454 – 1462
55. Pacifici R. E., Thomason A. R. Hybrid tyrosine kinase/ cytokine receptors transmit mitogenic signals in response to ligand. J. Biol. Chem 1993; 269: 1571 – 1574
56. Palacios R., Steinmetz M. IL3–dependent mouse clones that express B-220 surface antigen, contain Ig genes in gem-line configuration, and generate B lymphocytes in vivo. Cell 1985; 41: 727 – 734
57. Pallard C., Gouilleux F., Charon M., Groner B., Gisselbrecht S., Dusanter-Fourt I. Interleukin-3, erythropoietin. and prolactin activate a STAT5–like factor in lymphoid cells. J. Biol. Chem 1995; 270: 15942 – 15945
58. Penta K., Sawyer S. T. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STATS in erythroid cells. J. Biol. Chem 1995; 270: 31282 – 31287
59. Quelle D. E., Wojchowski D. M. Localized cytosolic domains of the erythropoietin receptor regulate growth signaling and down-modulate responsiveness to granulocyte-macrophage colony-stimulating factor. Proc. Natl Acad. Sci. USA 1991; 88: 4801 – 4805
60. Quelle F. W., Wang D., Nosaka T., Thierfeler W. E., Stravopodis D., Weinstein Y., Ihle J. N. Erythropoietin induces activation of STAT5 through association with specific tyrosines on the receptor that are not required for a nitogenic response. Mol. Cell. Biol 1996; 16: 1622 – 1631
61. Reissmann K. R. Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood 1950; 5: 372 – 380
62. Ren H. Y., Komatsu N., Shimizu R., Okada K., Miura Y. Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-gamma 1 in a human erythropoietin-dependent cell line. J. Biol. Chem 1994; 269: 19633 – 19638
63. Ruscetti S. K., Janesch N. J., Chakraborti A., Sawyer S. T., Hankins W. D. Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line. J. Virol 1990; 63: 1057 – 1062
64. Sakamaki K., Wang H. M., Miyajima I., Kitamura T., Todokoro K., Harada N., Miyajima A. Ligand-dependent activation of chimeric receptors with the cytoplasmic domain of the interleukin-3 receptor β subunit (β IL3). J. Biol. Chem 1993; 268: 15833 – 15839
65. Shibuya T., Mak T. W. Isolation and induction of erythroleukernic cell lines with properties of erythroid progenitor burst-forming cell (BFU-E) and erythroid precursor cell (CFU-E). Proc. Natl. Acad. Sci. USA 1983; 80: 3721 – 3725
66. Sigounas G., Cao H., Fox H., Schecter A., Hankins W. D. Hemin inducibility of erythropoietin-dependent cell lines. Blood 1987; 70: 161a
67. Spivak J. L., Pham T., Isaacs M., Hankins W. D. Erythmpoietin is both a mitogen and a survival factor. Blood 1991; 77: 1228 – 1233
68. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 1995; 268: 251 – 255
69. Tauchi T., Feng G. S., Shen R., Hoatlin M., Bagby G. C., Jr, Kabat D., Lu L., Broxmeyer H. E. Involvement of SH2–containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction. J. Biol. Chem 1995; 270: 5631 – 5635
70. Taxman D. J., Wojchowski D. M. Erythropoietin-induced transcription at the murine β maj-globin promoter. A central role for GATA-1. J. Biol. Chem 1995; 270: 6619 – 6627
71. Todokoro R., Kanazawa S., Amanuma H., Ikawa Y. Specific binding of erythropoietin to its receptor on responsive mouse erythroleukemia cells. Proc. Natl. Acad Sci. USA 1987; 84: 4126 – 4130
72. Tsuyuoka R., Takahashi T., Suzuki A., Sasaki Y., Nakamura K., Fukumoto M., Ohmori K., Ohno Y., Nakao K. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles. Stem Cells 1995; 13: 54 – 64
73. Wakao H., Gouilleux F., Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 1994; 13: 2182 – 2191
74. Witthuhn B. A., Quelle F. W., Silvennoinen O., Yi T., Tang B., Miura O., Ihle J. N. JAK2 associates with the crythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993; 74: 221 – 236
75. Wolff L., Kaminchik J., Hankins W. D., Ruscetti S. K. Sequence comparisons of the anemia-and polycythemia-inducing strains of Friend spleen focus-forming virus. J. Virol 1985; 53: 570 – 578
76. Wu H., Liu X., Jaenisch R., Lodish H. F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83: 59 – 67
77. Zhuang H., Patel S. V., He T. C., Sonsteby S. K., Niu Z., Wojchowski D. M. Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J. Biol. Chem 1994; 269: 21411 – 21414